Fidelity Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.32B | Buy |
45,672,024
+17,626,713
| +63% | +$822M | 0.12% | 137 |
|
|
2025
Q4 | $827M | Buy |
28,045,311
+15,741,014
| +128% | +$428M | 0.04% | 349 |
|
|
2025
Q3 | $318M | Sell |
12,304,297
-7,341,167
| -37% | -$205M | 0.02% | 674 |
|
|
2025
Q2 | $542M | Sell |
19,645,464
-1,484,565
| -7% | -$39.1M | 0.03% | 457 |
|
|
2025
Q1 | $599M | Buy |
21,130,029
+2,465,395
| +13% | +$87.5M | 0.04% | 390 |
|
|
2024
Q4 | $776M | Buy |
18,664,634
+1,282,469
| +7% | +$61.3M | 0.05% | 325 |
|
|
2024
Q3 | $1.16B | Sell |
17,382,165
-3,779,120
| -18% | -$347M | 0.07% | 234 |
|
|
2024
Q2 | $2.51B | Buy |
21,161,285
+7,561,448
| +56% | +$957M | 0.16% | 91 |
|
|
2024
Q1 | $1.45B | Buy |
13,599,837
+7,206,486
| +113% | +$726M | 0.1% | 175 |
|
|
2023
Q4 | $636M | Buy |
6,393,351
+2,549,779
| +66% | +$214M | 0.05% | 350 |
|
|
2023
Q3 | $397M | Sell |
3,843,572
-620,315
| -14% | -$69.2M | 0.03% | 461 |
|
|
2023
Q2 | $542M | Buy |
4,463,887
+499,693
| +13% | +$66.7M | 0.05% | 398 |
|
|
2023
Q1 | $609M | Buy |
3,964,194
+269,144
| +7% | +$44.4M | 0.06% | 349 |
|
|
2022
Q4 | $664M | Buy |
3,695,050
+1,549,061
| +72% | +$253M | 0.07% | 295 |
|
|
2022
Q3 | $254M | Sell |
2,145,989
-560,665
| -21% | -$85.1M | 0.03% | 587 |
|
|
2022
Q2 | $387M | Buy |
2,706,654
+459,992
| +20% | +$65.7M | 0.04% | 460 |
|
|
2022
Q1 | $387M | Sell |
2,246,662
-1,953,071
| -47% | -$329M | 0.03% | 528 |
|
|
2021
Q4 | $1.07B | Sell |
4,199,733
-3,161,000
| -43% | -$924M | 0.08% | 228 |
|
|
2021
Q3 | $2.83B | Buy |
7,360,733
+145,714
| +2% | +$53.7M | 0.22% | 71 |
|
|
2021
Q2 | $1.7B | Buy |
7,215,019
+1,452,440
| +25% | +$260M | 0.13% | 124 |
|
|
2021
Q1 | $755M | Sell |
5,762,579
-2,183,120
| -27% | -$316M | 0.06% | 290 |
|
|
2020
Q4 | $830M | Sell |
7,945,699
-26,275,625
| -77% | -$2.66B | 0.07% | 255 |
|
|
2020
Q3 | $2.42B | Sell |
34,221,324
-3,310,819
| -9% | -$231M | 0.24% | 66 |
|
|
2020
Q2 | $2.41B | Buy |
37,532,143
+12,772,752
| +52% | +$699M | 0.27% | 62 |
|
|
2020
Q1 | $742M | Buy |
24,759,391
+8,724,935
| +54% | +$201M | 0.1% | 181 |
|
|
2019
Q4 | $314M | Buy |
16,034,456
+3,650,327
| +29% | +$64.8M | 0.03% | 469 |
|
|
2019
Q3 | $197M | Sell |
12,384,129
-387,847
| -3% | -$5.73M | 0.02% | 625 |
|
|
2019
Q2 | $187M | Sell |
12,771,976
-2,442,229
| -16% | -$52.5M | 0.02% | 663 |
|
|
2019
Q1 | $296M | Sell |
15,214,205
-62,240
| -0.4% | -$1.16M | 0.04% | 494 |
|
|
2018
Q4 | $213M | Buy |
+15,276,445
| New | +$251M | 0.03% | 570 |
|
Other funds holding MRNA
VCM
VPM
TP